Insider Transactions in Q1 2024 at Seres Therapeutics, Inc. (MCRB)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2024
|
Thomas Des Rosier Chief Legal Officer and EVP |
SELL
Open market or private sale
|
Direct |
3,939
-3.16%
|
$3,939
$1.08 P/Share
|
|
Feb 16
2024
|
Eric D. Shaff CEO and President |
SELL
Open market or private sale
|
Direct |
11,549
-7.86%
|
$11,549
$1.08 P/Share
|
|
Feb 16
2024
|
Matthew R. Henn |
SELL
Open market or private sale
|
Direct |
4,170
-6.17%
|
$4,170
$1.08 P/Share
|
|
Feb 16
2024
|
Teresa L. Young |
SELL
Open market or private sale
|
Direct |
3,374
-17.68%
|
$3,374
$1.08 P/Share
|
|
Feb 16
2024
|
Lisa Von Moltke |
SELL
Open market or private sale
|
Direct |
4,400
-20.57%
|
$4,400
$1.08 P/Share
|
|
Feb 16
2024
|
David S. Ege |
SELL
Open market or private sale
|
Direct |
5,010
-6.35%
|
$5,010
$1.08 P/Share
|
|
Feb 16
2024
|
David Arkowitz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,939
-2.11%
|
$3,939
$1.08 P/Share
|
|
Feb 15
2024
|
Thomas Des Rosier Chief Legal Officer and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
10,625
+7.86%
|
-
|
|
Feb 15
2024
|
Eric D. Shaff CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+17.54%
|
-
|
|
Feb 15
2024
|
Matthew R. Henn |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+14.27%
|
-
|
|
Feb 15
2024
|
Teresa L. Young |
BUY
Exercise of conversion of derivative security
|
Direct |
10,625
+35.77%
|
-
|
|
Feb 15
2024
|
Lisa Von Moltke |
BUY
Exercise of conversion of derivative security
|
Direct |
11,875
+35.7%
|
-
|
|
Feb 15
2024
|
David S. Ege |
BUY
Exercise of conversion of derivative security
|
Direct |
11,875
+13.09%
|
-
|
|
Feb 15
2024
|
David Arkowitz Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,625
+5.39%
|
-
|